Background: Children with cerebral palsy may be at greater risk of being overweight or obese than their typically developed peers due to a number of biomechanical, behavioural, or medical issues that restrict participation. It has been a concern of our multi-disciplinary team that a greater number of children with cerebral palsy were presenting as overweight or obese. However, there are conflicting results in the literature as to prevalence and trends of overweight and obesity in these children.
Aims: To assess the prevalence of overweight and obesity in children with cerebral palsy presenting to our movement analysis laboratory over a 20-year time period.
Methods: A retrospective analysis was conducted of the laboratory database. Inclusion criteria were ambulatory children with a diagnosis of spastic cerebral palsy aged between 4 and 17 years inclusive. Height, weight, physical classification of cerebral palsy and functional level of impairment were extracted. Body mass index was calculated and data were analysed according to 4- × 5-year time periods.
Results: There were 1021 children included in this study. There were no significant findings for increasing trends of overweight and obesity across time. Prevalence of obesity and combined overweight and obesity in the most recent time period (2015-2019) was 7.1% and 20% respectively.
Conclusions: Prevalence of overweight and obesity is not increasing in Irish ambulatory children with cerebral palsy. However, a higher prevalence of overweight and obesity was evident when compared with their typically developed Irish peers. It is therefore important that prevalence and trends are monitored.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11845-020-02294-4 | DOI Listing |
Study Objectives: The prevalence of obstructive sleep apnea (OSA) increases dramatically in adolescents with overweight or obesity. The gold standard for diagnosis of OSA is in-laboratory polysomnography (PSG). However, access to PSG can be challenging, necessitating development of alternative devices.
View Article and Find Full Text PDFDiabetes Technol Ther
January 2025
Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, USA.
Adults with type 1 diabetes (T1D) are increasingly overweight or obese, in part due to intensive insulin therapy. Newer non-insulin medications targeting both hyperglycemia and weight loss are approved for people with type 2 diabetes. These drugs also reduce cardiovascular disease, the major cause of mortality in people with diabetes.
View Article and Find Full Text PDFChronobiol Int
January 2025
Department of Nutrition and Dietetics, Firat University, Elazig, Turkey.
The effects of chronotype and diet on obese individuals have been reported in previous studies. This study aimed to examine the relationship between the Mediterranean-DASH intervention for neurodegenerative delay (MIND) diet, chronotype and lifestyle factors in different types of overweight and obese people. 1100 obese individuals participated in this cross-sectional study.
View Article and Find Full Text PDFFront Med (Lausanne)
December 2024
Department of Cardiology, The Third Hospital of Mianyang/Sichuan Mental Health Center, Mianyang, Sichuan, China.
Aim: We aimed to systematically assess whether the level of body roundness index (BRI) is associated with the risk of developing chronic kidney disease (CKD) in US adults.
Methods: The studied data was extracted from the National Health and Nutrition Examination Survey (NHANES) spanning from 1999 to 2018. A total of 29,062 participants aged ≥20 years with complete information about BRI and CKD were included in this study.
Front Public Health
January 2025
Department of Physical Education, Anhui University of Technology, Ma'anshan, China.
Objective: This study aimed to investigate the impact of underweight, overweight, and obesity on the growth and development of preschoolers by comparing body shape characteristics across different weight statuses.
Methods: A total of 729 preschoolers (5.2 ± 0.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!